D.M. Tschaen

Publications

152

Citations

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

D.M. Tschaen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, molecular pharmacology, and medicinal chemistry.

Top concepts

PharmacologyMedicineOrganic ChemistryMedicinal ChemistryMolecular PharmacologyChemistryEngineeringBiochemistryNeuroscienceDrug Discovery

Publications per year

1988–2005

Publications

An efficient synthesis of 4-benzoyloxyazetidinone: an important carbapenem intermediate

D.M. Tschaen, L. M. FUENTES, Joseph E. Lynch et al. · Tetrahedron Letters · 1988 · 53 citations

Organic Chemistry, Efficient Synthesis, Chemistry +3

Methods for the Synthesis of 5,6,7,8-Tetrahydro-1,8-naphthyridine Fragments for α<sub>V</sub>β<sub>3</sub> Integrin Antagonists

Frederick W. Hartner, Yi Hsiao, Kan K. Eng et al. · The Journal of Organic Chemistry · 2004 · 45 citations

Enantioselective Preparation of Ring-Fused 1-Fluorocyclopropane-1-carboxylate Derivatives: En Route to mGluR 2 Receptor Agonist MGS0028

Fei Zhang, Zhiguo J. Song, D.M. Tschaen et al. · Organic Letters · 2004 · 33 citations

Molecular Pharmacology, Medicinal Chemistry, Receptor Agonist Mgs0028 +15

Practical Synthesis of a Neuropeptide Y Antagonist via Stereoselective Addition to a Ketene

Takehiko Iida, Hiroki Satoh, Kenji Maeda et al. · The Journal of Organic Chemistry · 2005 · 21 citations

Engineering, Organic Chemistry, Peptide Science +19

Rows per page

1–4 of 4